New Products

MIAMI — Green Smoke e-cigarettes brand announced that smokers can now buy a reusable sleek carrying case for their disposables and rechargeables, to enjoy a variety of flavors and nicotine levels.

The new carrying case holds the equivalent of 2 packs of cigarettes in vapor volume.

PITTSBURGH — Mylan has launched a generic contraceptive therapy, the drug maker said Tuesday.

Mylan, through its Mylan Pharmaceuticals subsidiary, announced the launch of norethindrone tablets in the 0.35-mg strength. The drug is a generic version of Actavis' Nor-Q.D. tablets, which are taken on a 28-day cycle to prevent pregnancy. Mylan is partnering with Famy Care, which filed for and received Food and Drug Administration approval for the drug.

HAIFA, Israel — Self-reported medication adherence rates increased among Type 2 diabetes patients using a mobile app, the maker of the app said Monday.

MediSafe Project said it reviewed adherence rates among Type 2 diabetic users of its app, finding compliance rates at least 26% higher than the generate rate for long-term diabetes therapies, which the World Health Organization reports as 50%. A January 2013 study of the app, which the company launched in November 2012, found similar rates.

PITTSBURGH — Mylan has launched a generic drug for treating cholesterol problems, the company said Monday.

Mylan announced the launch of generic fenofibric acid delayed-release capsules in the 45-mg and 135-mg strengths.

The drug is a generic version of Abbott's Trilipix, designed for use in combination with statin drugs and diet to reduce triglycerides and increase high-density lipoprotein or "good" cholesterol.

Various versions of the drug had sales of about $553.6 million during the 12-month period that ended in March, according to IMS Health.

PARSIPPANY, N.J. — The Food and Drug Administration has approved a generic opioid painkiller made by Actavis, the drug maker said.

HACKETTSTOWN, N.J. — Consumers have a brand new way to enjoy the trademark Snickers combination of chocolate, peanuts, caramel and nougat. New Snickers Bites are small "pop 'em in your mouth" milk chocolate cubes that deliver classic Snickers flavor in a bite-sized treat. The bite-sized unwrapped cubes are now available nationwide in a 2.83-oz. sharing size bag at a suggested retail price of $1.49 and an 8-oz. stand-up pouch for $2.99.

As the U.S. population becomes increasingly diverse, meeting the beauty needs of ethnic shoppers continues to become increasingly vital and, as evidenced by the influx of new products, manufacturers are taking note and heeding the call.

According to the U.S. Census Bureau, in the year ended July 31, 2011, African-Americans, Latinos and other minorities accounted for 50.4% of all births. This was up from 49.5% from the 2010 Census taken April 1, 2010.

MUMBAI, India — The Food and Drug Administration has approved a generic diabetes drug made by Sun Pharmaceutical Industries, Sun said Friday.

The Indian generic drug maker announced the approval of repaglinide tablets in the 1-mg and 2-mg strengths, which are used in combination with diet and exercise to improve blood-sugar control in patients with Type 2 diabetes.